Published in Medical Letter on the CDC and FDA, August 30th, 2009
With the expansion of the Boots business, RESPeRATE will now be available nationally in the UK's two largest multiple pharmacy chains. InterCure entered the UK pharmacy market in 2008, achieving broad distribution at 1,400...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.